The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetesMANCHESTER, N.H. and GERMANTOWN, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ...

The "Diabetes Therapeutics and Diagnostics" has been added to ResearchAndMarkets.com's offering. The global diabetes therapeutics and diagnostics market is poised for significant growth, anticipated ...

WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. Its GAAP loss of $0.01 per share ...

According to the latest Mordor Intelligence report, the insulin delivery devices market size is estimated at USD 33.79 billion in 2026, and is expected to reach USD 49.23 billion by 2031, at a CAGR of ...

FAYETTEVILLE, GA, UNITED STATES, February 15, 2026 /EINPresswire.com/ -- Continuous glucose monitoring is essential for ...

Insulin is a generic prescription drug approved for blood sugar management in certain animals, including dogs. Learn how to ...

Insulin is a generic prescription drug approved for blood sugar management in certain animals, including cats. Learn how to save money on your cat's prescription.

According to the latest Mordor Intelligence report, the insulin delivery devices market size is estimated at USD 33.79 billion in 2026, and is ...

Regan Roat, MD, PhD, is an endocrinologist specializing in Type 1 and 2 diabetes, pregnancy care, gestational diabetes, and preconception counseling.

Sequel Med Tech and (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration.

Investors split as Abbott's diabetes unit forecasts strong growth while a serious FDA recall for its FreeStyle Libre 3 CGM creates major safety and reputational risks.